CLOV NASDAQ
Clover Health Investments, Corp.
1W: +3.1%
1M: +44.0%
3M: +78.2%
YTD: +49.4%
1Y: -2.4%
3Y: +256.4%
5Y: -51.8%
$3.55
-0.05 (-1.39%)
Weekly Expected Move ±8.9%
$3
$3
$3
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
0 bullish
1 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (52)
Lowe's, ZTO Express, Viavi Solutions And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Clover Health (CLOV) Q1 2026 Earnings Transcript
Clover targets 100-150 bps SG&A improvement in 2026 while expecting full-year GAAP net income profitability
Clover Health Q1 Earnings Meet Estimates, Sales Beat, Membership Rises
Clover Health Investments, Corp. (CLOV) Meets Q1 Earnings Estimates
Earnings Scheduled For May 6, 2026
Clover Health GAAP EPS of $0.05 beats by $0.02, revenue of $749.2M beats by $34.31M
Clover Health Reports First Quarter 2026 Results
Butterfly Network, Inc. (BFLY) Reports Q1 Loss, Beats Revenue Estimates
What’s next for UnitedHealth Group after Q1 earnings beat and guidance raise
Clover Health Investments, Corp. (NASDAQ:CLOV) Receives $2.90 Average Target Price from Analysts
Clover Health Investments Sees Unusually Large Options Volume (NASDAQ:CLOV)
Managed care stocks jump after UNH's Q1 report: Here are the 9 best Quant rated names
UnitedHealth lifts managed care peers after Q1 beat, guidance raise
Strength Seen in Butterfly Network (BFLY): Can Its 8.9% Jump Turn into More Strength?
Here's Why You Should Retain Clover Stock in Your Portfolio for Now
Managed care rebounds after Medicare rate decision
Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership
Clover Health Investments Target of Unusually Large Options Trading (NASDAQ:CLOV)
Insurers to receive extra $18B as Medicare overhauls Star Ratings system
Clover Health Investments appoints Clay Thornton as interim CFO
Clover Health Investments, Corp. (NASDAQ:CLOV) Receives $2.90 Consensus PT from Analysts
Clover Health Investments (NASDAQ:CLOV) Reaches New 52-Week Low on Analyst Downgrade
Medicare Advantage payments in focus as regulator says insurers yet to rein in costs
Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients
Extra premiums due to alleged Medicare overpayments topped $13B in 2025: WSJ
Clover Health Enters Collaboration to Be Part of CMS Aligned Network
Clover Health Investments, Corp. (NASDAQ:CLOV) Receives $3.23 Consensus Target Price from Brokerages
Here's Why You Should Retain Clover Stock in Your Portfolio for Now
Rising employee health insurance costs dampened wage growth: Fed survey
While everyone’s portfolio is in shambles, I’m at ATHs 🙏
Clover Health Q4 Earnings Meet Estimates, Sales Beat, Membership Rises
Clover Health Q4 Earnings Meet Estimates, Sales Beat, Membership Rises
Clover Health expects 46% membership growth and first full year GAAP profitability in 2026 while advancing cohort economics
Clover Health Investments, Corp. (CLOV) Q4 2025 Earnings Call Transcript
Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance
Here are the major earnings after the close Thursday
Earnings week ahead: NVDA, CRM, HD, BIDU, LOW, DELL, SNOW, AMC, ZM, and more
Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Standard BioTools (NASDAQ:LAB) versus Clover Health Investments (NASDAQ:CLOV) Critical Review
Clover Health (CLOV) Slides As Trump Medicare Advantage Shock And UnitedHealth Earnings Hit Insurer Sentiment
Clover Health Is Undervalued With Clear Signs Of A 2026 Profit Breakout
Here's Why You Should Retain CLOV Stock in Your Portfolio for Now
Clover Health Investments, Corp. (CLOV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026
Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost
Clover Health Investments, Corp. (NASDAQ:CLOV) Given Consensus Rating of “Hold” by Analysts
Here's Why You Should Retain CLOV Stock in Your Portfolio Now
Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference
Clover Health Investments, Corp. (CLOV) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Why Is Clover Health Investments (CLOV) Down 11.6% Since Last Earnings Report?
Clover Health: Smart Money Should Be Accumulating Ahead Of 2026 GAAP Profits